Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)
Clinical trial NCT03745989 · COMPLETED
Trial details
- NCT number
- NCT03745989
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2021-03-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.